Abstract:Objective To investigate clinical significance of serum adiponectin and 8-iso prostaglandin F2α in patients with chronic obstructive pulmonary disease (COPD) complicated with obstructive sleep apnea hypopnea syndrome (OSAHS). Methods A total of 120 patients were enrolled in this study. The patients were divided into COPD group (n?=?80 cases) and OS group (COPD combined with OSAHS, n?=?40 cases). The age, gender, smoking, body mass index (BMI), forced vital capacity rate of one second (FEV1%/FVC) were recorded. Serum levels of adiponectin and 8-iso prostaglandin F2α were measured by ELISA. Results There were no significant differences in age, gender, smoking, blood pressure, blood glucose and blood lipid between the two groups (P?>?0.05). Compared with patients with COPD, OS patients experienced increase in BMI and 8-iso prostaglandin F2α while decrease in FEV1%/FVC and adiponectin (P?0.05). After adjustment for age, gender, BMI, FEV1%/FVC and other confounding factors, OS has a negative relationship with adiponectin (β?=?-2.018) and positive relationship with 8-iso prostaglandin F2α (β?=?3.824) (P?0.05). Conclusions OS may increase the risk of metabolic disorders, cardiovascular diseases, and cerebrovascular diseases.